Literature DB >> 12705999

Impact of urinary incontinence and overactive bladder on quality of life.

Francesca Chiaffarino1, Fabio Parazzini, Maurizio Lavezzari, Vincenzo Giambanco.   

Abstract

OBJECTIVE: To assess the quality of life (QOL) of women with urinary incontinence (UI) or overactive bladder (OB) compared with women without UI.
METHODS: A case-control study conducted in Italy on risk factors for UI and OB. Information on QOL were collected using the SF-12 questionnaire, validated for Italian women.
RESULTS: A total of 1062 cases (258 had stress, 195 urge, 486 mixed UI and 123 OB without incontinence) and 1143 controls were interviewed. QOL, as assessed by the SF-12, was significantly impaired in cases compared with controls (p=0.0001); the mean SF-12 physical health score was 48.3 for controls, but 45.6, 42.0, 44.5 and 40.0 for cases with OB, urge, stress and mixed incontinence, respectively. Women with OB had significantly higher physical health scores than women with urge and mixed UI (p<0.005) (44.6 versus 41.7 and 41.3). Physical and mental health dimensions of cases significantly decreased with increasing severity of symptoms.
CONCLUSIONS: QOL was significantly impaired in women with UI or OB compared to controls. Physical and mental functioning tended to be more impaired in patients than in controls.

Entities:  

Mesh:

Year:  2003        PMID: 12705999     DOI: 10.1016/s0302-2838(03)00097-6

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  25 in total

1.  Epidemiological aspects of urinary incontinence in a female population of an Italian region.

Authors:  Rosaria Alvaro; Francesco Araco; Gianpiero Gravante; Roberto Sorge; John Overton; Ercole Vellone; Giulia Venturini; Emilio Piccione
Journal:  Int Urogynecol J       Date:  2010-02-24       Impact factor: 2.894

2.  Measuring quality of life in patients with stress urinary incontinence: is the ICIQ-UI-SF adequate?

Authors:  Zuzanna Kurzawa; Jason M Sutherland; Trafford Crump; Guiping Liu
Journal:  Qual Life Res       Date:  2018-05-08       Impact factor: 4.147

Review 3.  The puzzle of overactive bladder: controversies, inconsistencies, and insights.

Authors:  Roger R Dmochowski
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-06-27

4.  A spinal GABAergic mechanism is necessary for bladder inhibition by pudendal afferent stimulation.

Authors:  Meredith J McGee; Zachary C Danziger; Jeremy A Bamford; Warren M Grill
Journal:  Am J Physiol Renal Physiol       Date:  2014-08-20

5.  Female urinary incontinence: a cross-sectional study from a Thai rural area.

Authors:  Jittima Manonai; Aporn Poowapirom; Sompong Kittipiboon; Sanya Patrachai; Umaporn Udomsubpayakul; Apichart Chittacharoen
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-09-24

Review 6.  Overactive bladder and mixed incontinence.

Authors:  Sunshine Murray; Gary E Lemack
Journal:  Curr Urol Rep       Date:  2010-11       Impact factor: 3.092

7.  Establishing the content validity of the King's Health Questionnaire in men and women with overactive bladder in the US.

Authors:  Mary Kay Margolis; Vasudha Vats; Karin S Coyne; Con Kelleher
Journal:  Patient       Date:  2011       Impact factor: 3.883

8.  Is there an urban-rural-gradient in patients with urinary incontinence?

Authors:  Sebastian Wille; Kawa Katarzyna; Ulrike Ahrens; Okyaz Eminaga; Udo Engelmann; Paas Jenny
Journal:  Can Urol Assoc J       Date:  2014 Mar-Apr       Impact factor: 1.862

9.  The interaction of stress and urgency urinary incontinence and its effect on quality of life.

Authors:  Vatché A Minassian; Haiyan Sun; Xiaowei S Yan; Deseraé N Clarke; Walter F Stewart
Journal:  Int Urogynecol J       Date:  2014-10-03       Impact factor: 2.894

Review 10.  The role of acupuncture in managing overactive bladder; a review of the literature.

Authors:  James C Forde; Edward Jaffe; Benjamin V Stone; Alexis E Te; Geo Espinosa; Bilal Chughtai
Journal:  Int Urogynecol J       Date:  2016-01-06       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.